Your browser doesn't support javascript.
loading
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.
Maspero, Jorge F; Katelaris, Constance H; Busse, William W; Castro, Mario; Corren, Jonathan; Chipps, Bradley E; Peters, Anju T; Pavord, Ian D; Ford, Linda B; Sher, Lawrence; Rabe, Klaus F; Rice, Megan S; Rowe, Paul; Lu, Yufang; Harel, Sivan; Jagerschmidt, Alexandre; Khan, Asif H; Kamat, Siddhesh; Pirozzi, Gianluca; Amin, Nikhil; Ruddy, Marcella; Graham, Neil M H; Mannent, Leda P; Teper, Ariel.
Afiliación
  • Maspero JF; Fundación CIDEA, Buenos Aires, Argentina. Electronic address: jorge.maspero@fundacioncidea.org.ar.
  • Katelaris CH; Campbelltown Hospital, Campbelltown, NSW, Australia; Western Sydney University, Sydney, NSW, Australia.
  • Busse WW; University of Wisconsin School of Medicine and Public Health, Madison, Wis.
  • Castro M; Washington University School of Medicine, Saint Louis, Mo.
  • Corren J; David Geffen School of Medicine at UCLA, Los Angeles, Calif.
  • Chipps BE; Capital Allergy and Respiratory Disease Center, Sacramento, Calif.
  • Peters AT; Division of Allergy-Immunology and the Sinus and Allergy Center, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
  • Pavord ID; University of Oxford, Oxford, United Kingdom.
  • Ford LB; Asthma & Allergy Center, Bellevue, Neb.
  • Sher L; Peninsula Research Associates, Rolling Hills Estates, Calif.
  • Rabe KF; LungenClinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany; Christian-Albrechts-University of Kiel, Member of the German Center for Lung Research (DZL), Kiel, Germany.
  • Rice MS; Sanofi Genzyme, Cambridge, Mass.
  • Rowe P; Sanofi, Bridgewater, NJ.
  • Lu Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Harel S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Jagerschmidt A; Sanofi, Chilly-Mazarin, France.
  • Khan AH; Sanofi, Chilly-Mazarin, France.
  • Kamat S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Pirozzi G; Sanofi, Bridgewater, NJ.
  • Amin N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Ruddy M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Graham NMH; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Mannent LP; Sanofi, Chilly-Mazarin, France.
  • Teper A; Sanofi, Bridgewater, NJ.
J Allergy Clin Immunol Pract ; 8(2): 527-539.e9, 2020 02.
Article en En | MEDLINE | ID: mdl-31351189
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Asma / Sinusitis / Rinitis / Antiasmáticos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Asma / Sinusitis / Rinitis / Antiasmáticos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2020 Tipo del documento: Article